[1]蒋艺婕,杜科,华飞.铁代谢异常及铁死亡与多囊卵巢综合征关系的研究进展[J].国际内分泌代谢杂志,2023,43(02):124-127.[doi:10.3760/cma.j.cn121383-20220122-01046]
　Jiang Yijie,Du Ke,Hua Fei..Relationship between abnormal iron metabolism, ferroptosis and polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(02):124-127.[doi:10.3760/cma.j.cn121383-20220122-01046]
点击复制

铁代谢异常及铁死亡与多囊卵巢综合征关系的研究进展()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年02期
页码:
124-127
栏目:
综述
出版日期:
2023-03-20

文章信息/Info

Title:
Relationship between abnormal iron metabolism, ferroptosis and polycystic ovary syndrome
作者:
蒋艺婕; 杜科; 华飞
常州市第一人民医院内分泌代谢科,苏州大学附属第三医院,常州 213003
Author(s):
Jiang Yijie;  Du Ke;  Hua Fei.
Department of Endocrinology and Metabolism, the First People's Hospital of Changzhou, the Third Affiliated Hospital of Soochow University, Changzhou 213003, China
关键词:
多囊卵巢综合征;  铁代谢;  铁死亡
Keywords:
Polycystic ovary syndrome;  Iron metabolism;  Ferroptosis
DOI:
10.3760/cma.j.cn121383-20220122-01046
摘要:
铁代谢参与机体许多重要生理活动,铁死亡是一种新型程序性细胞死亡方式,人们对铁代谢、铁死亡在多囊卵巢综合征(PCOS)中的作用了解局限。在患有PCOS的患者中发现铁超载现象,且铁代谢也对PCOS患者的激素、代谢、生殖产生直接或间接影响。铁死亡亦可造成PCOS患者代谢紊乱。目前,PCOS的发病机制不明,通过对铁代谢、铁死亡的了解阐明其与PCOS之间的关系,以期探索出对PCOS的治疗新靶点。
Abstract:
Iron metabolism is involved in many important physiological activities of the body, and ferroptosis is a new type of programmed cell death. Little is known about the role of iron metabolism and ferroptosis in polycystic ovary syndrome(PCOS). Iron overload has been found in patients with PCOS, and iron metabolism has direct or indirect effects on hormones, metabolism, and reproduction in patients with PCOS. Ferroptosis can also cause metabolic disorders in patients with PCOS. At present, the pathogenesis of PCOS is unknown. By understanding iron metabolism, ferroptosis and their relationship with PCOS are useful in exploring new targets for the treatment of PCOS.

参考文献/References:

[1] Chen X,Li J,Kang R,et al.Ferroptosis:machinery and regulation[J].Autophagy,2021,17(9):2054-2081.DOI:10.1080/15548627.2020.1810918.
[2] Dixon SJ,Lemberg KM,Lamprecht MR,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.DOI:10.1016/j.cell.2012.03.042.
[3] Koleini N,Shapiro JS,Geier J,et al.Ironing out mechanisms of iron homeostasis and disorders of iron deficiency[J].J Clin Invest,2021,131(11):e148671.DOI:10.1172/JCI148671.
[4] Li J,Cao F,Yin HL,et al.Ferroptosis:past,present and future[J].Cell Death Dis,2020,11(2):88.DOI:10.1038/s41419-020-2298-2.
[5] Galluzzi L,Vitale I,Aaronson SA,et al.Molecular mechanisms of cell death:recommendations of the Nomenclature Committee on Cell Death 2018[J].Cell Death Differ,2018,25(3):486-541.DOI:10.1038/s41418-017-0012-4.
[6] Bayr H,Anthonymuthu TS,Tyurina YY,et al.Achieving life through death:redox biology of lipid peroxidation in ferroptosis[J].Cell Chem Biol,2020,27(4):387-408.DOI:10.1016/j.chembiol.2020.03.014.
[7] Han C,Liu Y,Dai R,et al.Ferroptosis and its potential role in human diseases[J].Front Pharmacol,2020,11:239.DOI:10.3389/fphar.2020.00239.
[8] Chen X,Yu C,Kang R,et al.Iron metabolism in ferroptosis[J].Front Cell Dev Biol,2020,8:590226.DOI:10.3389/fcell.2020.590226.
[9] Yan B,Ai Y,Sun Q,et al.Membrane Damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1[J].Mol Cell,2021,81(2):355-369.e10.DOI:10.1016/j.molcel.2020.11.024.
[10] Yin J,Hong X,Ma J,et al.Serum trace elements in patients with polycystic ovary syndrome:a systematic review and meta-analysis[J].Front Endocrinol(Lausanne),2020,11:572384.DOI:10.3389/fendo.2020.572384.
[11] Luque-Ramírez M,Álvarez-Blasco F,Alpañés M,et al.Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome[J].J Clin Endocrinol Metab,2011,96(3):846-852.DOI:10.1210/jc.2010-2211.
[12] Luque-Ramírez M,Alvarez-Blasco F,Botella-Carretero JI,et al.Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses[J].Diabetes Care,2007,30(9):2309-2313.DOI:10.2337/dc07-0642.
[13] Adamska A,ebkowska A,Krentowska A,et al.The association between serum ferritin concentration and visceral adiposity estimated by whole-body DXA scan in women with polycystic ovary syndrome[J].Front Endocrinol(Lausanne),2020,10:873.DOI:10.3389/fendo.2019.00873.
[14] Sung HK,Song E,Jahng JWS,et al.Iron induces insulin resistance in cardiomyocytes via regulation of oxidative stress[J].Sci Rep,2019,9(1):4668.DOI:10.1038/s41598-019-41111-6.
[15] Chappell NR,Zhou B,Schutt AK,et al.Prenatal androgen induced lean PCOS impairs mitochondria and mRNA profiles in oocytes[J].Endocr Connect,2020,9(3):261-270.DOI:10.1530/EC-19-0553.
[16] Ng SW,Norwitz SG,Norwitz ER.The impact of iron overload and ferroptosis on reproductive disorders in humans:implications for preeclampsia[J].Int J Mol Sci,2019,20(13):3283.DOI:10.3390/ijms20133283.
[17] 张利平,黄娟娟,王娟,等.铁代谢对多囊卵巢综合征患者妊娠结局的影响[J].中华妇幼临床医学杂志(电子版),2017,13(1):65-70.DOI:10.3877/cma.j.issn.1673-5250.2017.01.012.
[18] Masjedi F,Keshtgar S,Zal F,et al.Effects of vitamin D on steroidogenesis,reactive oxygen species production,and enzymatic antioxidant defense in human granulosa cells of normal and polycystic ovaries[J].J Steroid Biochem Mol Biol,2020,197:105521.DOI:10.1016/j.jsbmb.2019.105521.
[19] Zhang L,Wang F,Li D,et al.Transferrin receptor-mediated reactive oxygen species promotes ferroptosis of KGN cells via regulating NADPH oxidase 1/PTEN induced kinase 1/acyl-CoA synthetase long chain family member 4 signaling[J].Bioengineered,2021,12(1):4983-4994.DOI:10.1080/21655979.2021.1956403.
[20] Liu H,Xie J,Fan L,et al.Cryptotanshinone protects against PCOS-induced damage of ovarian tissue via regulating oxidative stress,mitochondrial membrane potential,inflammation,and apoptosis via regulating ferroptosis[J].Oxid Med Cell Longev,2022,2022:8011850.DOI:10.1155/2022/8011850.
[21] Zhang Y,Hu M,Jia W,et al.Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats[J].J Endocrinol,2020,246(3):247-263.DOI:10.1530/JOE-20-0155.
[22] Zhang J,Ding N,Xin W,et al.Quantitative proteomics reveals that a prognostic signature of the endometrium of the polycystic ovary syndrome women based on ferroptosis proteins[J].Front Endocrinol(Lausanne),2022,13:871945.DOI:10.3389/fendo.2022.871945.
[23] Nasri F,Zare M,Doroudchi M,et al.Proteome analysis of CD4(+)T cells reveals differentially expressed proteins in infertile polycystic ovary syndrome patients[J].Endocr Metab Immune Disord Drug Targets,2021,21(11):1998-2004.DOI:10.2174/1871530320666201119152323.
[24] Zhang J,Bao Y,Zhou X,et al.Polycystic ovary syndrome and mitochondrial dysfunction[J].Reprod Biol Endocrinol,2019,17(1):67.DOI:10.1186/s12958-019-0509-4.
[25] Gao M,Yi J,Zhu J,et al.Role of mitochondria in ferroptosis[J].Mol Cell,2019,73(2):354-363.e3.DOI:10.1016/j.molcel.2018.10.042.
[26] Schube U,Nowicki M,Jogschies P,et al.Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration[J].J Clin Endocrinol Metab,2014,99(1):229-239.DOI:10.1210/jc.2013-2692.
[27] Shirazi SH,Pourghassem Gargari B,Izadi A,et al.Effect of vitamin E on serum Levels of vascular endothelial growth factor and angiopoietin-1 in women with polycystic ovary syndrome:a pilot randomized,placebo-controlled trial[J].Int J Fertil Steril,2021,15(1):44-50.DOI:10.22074/ijfs.2020.45677.
[28] Tan W,Dai F,Yang D,et al.MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome[J].Front Immunol,2022,13:967151.DOI:10.3389/fimmu.2022.967151.

相似文献/References:

[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
　Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(02):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]杨健姝,华飞,唐暎,等.二甲双胍在多囊卵巢综合征患者妊娠期的应用[J].国际内分泌代谢杂志,2014,(03):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
　Yang Jianshu,Hua Fei,Tang Ying,et al.The application of metformin in the pregnant patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(02):176.[doi:10.3760/cma.j.issn.1673-4157.2014.03.009]
[3]姚敏,何启军,吴秀继,等.2型糖尿病患者铁代谢与血栓弹力图 相关性研究[J].国际内分泌代谢杂志,2016,36(05):296.[doi:10.3760/cma.j.issn.1673-4157.2016.05.03]
　Yao Min*,He Qijun,Wu Xiuji,et al.Correlation between iron metabolism and thrombelastography in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(02):296.[doi:10.3760/cma.j.issn.1673-4157.2016.05.03]
[4]乔冠华,李强.胰高血糖素样肽-1受体激动剂治疗多囊卵巢综合征的研究进展[J].国际内分泌代谢杂志,2017,37(03):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
　Qiao Guanhua,Li Qiang..Glucagon like peptide-1 receptor agonist in the treatment of polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2017,37(02):181.[doi:10.3760/cma.j.issn.1673-4157.2017.03.010]
[5]司马盼盼 孙良阁.多囊卵巢综合征与自身免疫性甲状腺疾病的相关性[J].国际内分泌代谢杂志,2018,38(03):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
　Sima Panpan,Sun Liangge..Correlation between polycystic ovary syndrome and autoimmune thyroid disease[J].International Journal of Endocrinology and Metabolism,2018,38(02):163.[doi:10.3760/cma.j.issn.1673-4157.2018.03.005]
[6]廖鑫 张开羽 高琳 张晗 张琳 邓凡曲 黄琦 李思成 张凌.多囊卵巢综合征患者血清PTX3、vaspin 水平的观察研究[J].国际内分泌代谢杂志,2018,38(04):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
　Liao Xin*,Zhang Kaiyu,Gao Lin,et al.Study of serum PTX3 and vaspin levels in patients with polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(02):228.[doi:10.3760/cma.j.issn.1673-4157.2018.04.003]
[7]袁铖 华飞.Th1/Th2失衡与多囊卵巢综合征[J].国际内分泌代谢杂志,2020,40(01):59.[doi:10.3760/cma.j.issn.1673-4157.2020.01.014]
　Yuan Cheng,Hua Fei.Th1/Th2 imbalance and polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2020,40(02):59.[doi:10.3760/cma.j.issn.1673-4157.2020.01.014]
[8]杜岑,都健.铁死亡调控机制与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2020,40(05):340.[doi:10.3760/cma.j.cn121383-20191227-12074]
　Du Cen,Du Jian.The mechanism of ferroptosis regulation and non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2020,40(02):340.[doi:10.3760/cma.j.cn121383-20191227-12074]
[9]梁杏燕,赵捷,马红霞.自身免疫性甲状腺疾病对多囊卵巢综合征不良妊娠结局的影响[J].国际内分泌代谢杂志,2022,42(06):481.[doi:10.3760/cma.j.cn121383-20211016-10036]
　Liang Xingyan,Zhao Jie,Ma Hongxia..Influence of autoimmune thyroid disease on adverse pregnant outcome in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2022,42(02):481.[doi:10.3760/cma.j.cn121383-20211016-10036]
[10]车悦,陶弢.饮食干预对多囊卵巢综合征患者生殖功能影响的研究进展[J].国际内分泌代谢杂志,2023,43(01):62.[doi:10.3760/cma.j.cn121383-20211002-10001]
　Che Yue,Tao Tao..Research progress of dietary intervention impact on reproduction in polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2023,43(02):62.[doi:10.3760/cma.j.cn121383-20211002-10001]

备注/Memo

备注/Memo:
基金项目:江苏省妇幼健康科研项目(F201803); 常州市卫生人才培养工程资助项目(2016ZCLJ020)
通信作者:华飞,Email:huafei1970@suda.edu.cn
更新日期/Last Update: 2023-04-15